SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-008004
Filing Date
2020-05-19
Accepted
2020-05-19 09:28:20
Documents
5
Period of Report
2020-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k051920.htm 8-K 42405
2 EX-10.1 a101crdf51920.htm EX-10.1 124338
3 EX-99.1 a991crdf051920.htm EX-99.1 10455
4 cardifflogorgbtm1.jpg GRAPHIC 176318
5 image01.jpg GRAPHIC 50931
  Complete submission text file 0001628280-20-008004.txt   476957
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 20891839
SIC: 2836 Biological Products, (No Diagnostic Substances)